Licence Changes & Product Updates

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

A careful stepwise approach is needed when reducing...

Prescribers advised not to use newer anticoagulants in patients with antiphospholipid syndrome

Prescribers advised not to use newer anticoagulants in patients with antiphospholipid syndrome

Direct-acting oral anticoagulants (DOACs) should not...

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Trimovate available to prescribe again

Trimovate available to prescribe again

GPs can prescribe the steroid/antibiotic cream Trimovate...

Teething products containing lidocaine to become 'P' medicines

Teething products containing lidocaine to become 'P' medicines

All oral lidocaine-containing preparations indicated...

Long-acting anticholinergic licensed for childhood asthma

Long-acting anticholinergic licensed for childhood asthma

Spiriva Respimat (tiotropium) is now licensed for use...

Capsule inhalation warning for tiotropium inhaler

Capsule inhalation warning for tiotropium inhaler

Train patients prescribed Braltus (tiotropium) in the...

PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease

PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease

Repatha (evolocumab) can now be prescribed to reduce...

Diabetes test strips recalled

Diabetes test strips recalled

Patients with diabetes who use the Accu-Chek Aviva...